March 11, 2026
Kirsten Bryant, PhD, has been awarded a $100,000 seed grant for her project that seeks to define and target metabolic changes associated with RAS inhibition in pancreatic ductal adenocarcinoma.
May 23, 2025
June 28, 2024
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
May 14, 2024
Graduate and postdoctoral students attended the Channing J. Der Annual Career Symposium on May 1 to learn about different science career paths they might consider after completing their training.
November 16, 2023
November 16, 2023
Kirsten Bryant, PhD, shares what motivates her in the lab, how mentorship and advocacy have fueled her passion for pancreatic cancer research, and why she's encouraged by progress made in the past decade.
August 26, 2022
UNC Lineberger’s Channing Der, PhD, and Kirsten Bryant, PhD, are among seven recipients of the inaugural Pancreatic Cancer Action Network (PanCAN) Therapeutic Accelerator Collaborative Award, which provides a total of $340,000 in grant support over two years.
April 16, 2021
The Pancreatic Cancer Center of Excellence brings together researchers, clinicians and staff to provide excellent multidisciplinary patient care and generate research discoveries that can be translated into new, more effective approaches for pancreatic cancer.
February 8, 2021
Kirsten Bryant, PhD, was named a 2021 New York Academy of Science Rising Star in Cancer Metabolism, honoring her work as an early career researcher.
June 16, 2020
Kirsten Bryant, PhD, will attend the Forbeck Forum for a series of talks on “Emerging Strategies to Overcome Heterogeneous Resistance Mechanisms.”